Efficacy and Safety of Baricitinib in Refractory Chronic Graft-Versus-Host Disease (cGVHD): Preliminary Analysis Results of a Phase 1/2 Study von Holtzman, Noa G., Im, Annie, Ostojic, Alen, Curtis, Lauren M., Parsons-Wandell, Laura, Nashed, Jeannette, Peer, Cody, Figg, William D., Magone, M. Teresa, Cowen, Edward W, Mays, Jacqueline W, Hakim, Frances T., Rose, Jeremy J., Pouzelles, Marie C, Taylor, Naomi, Pavletic, Steven Z.

Volltext